Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Canadian Sec - Delayed Quote CAD

PreveCeutical Medical Inc. (PREV.CN)

Compare
0.0300
0.0000
(0.00%)
At close: February 20 at 11:58:51 AM EST
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
1,011.8360
963.1240
1,058.8200
897.8510
2,163.2330
Operating Income
-1,011.8360
-963.1240
-1,058.8200
-897.8510
-2,163.2330
Net Non Operating Interest Income Expense
-324.9400
-309.5290
-237.2740
-466.8960
-640.0420
Other Income Expense
-19.4010
-1.8180
-185.2760
-382.3010
-1,003.9930
Pretax Income
-1,356.1770
-1,274.4710
-1,481.3700
-1,747.0480
-3,807.2680
Tax Provision
--
--
--
-20.4770
-6.1500
Net Income Common Stockholders
-1,356.1770
-1,274.4710
-1,481.3700
-1,726.5710
-3,801.1180
Diluted NI Available to Com Stockholders
-1,356.1770
-1,274.4710
-1,481.3700
-1,726.5710
-3,801.1180
Basic EPS
-0.00
-0.00
-0.00
-0.00
-0.01
Diluted EPS
-0.00
-0.00
-0.00
-0.00
-0.01
Basic Average Shares
535,909.9520
535,303.3590
521,789.9340
507,953.2380
455,868.8700
Diluted Average Shares
535,909.9520
535,303.3590
521,789.9340
507,953.2380
455,868.8700
Total Operating Income as Reported
-1,011.8360
-963.1240
-1,058.8200
-897.8510
-2,140.2130
Rent Expense Supplemental
4.9160
6.2360
3.7860
5.2820
--
Total Expenses
1,011.8360
963.1240
1,058.8200
897.8510
2,163.2330
Interest Expense
324.9400
309.5290
237.2740
466.8960
640.0420
Net Interest Income
-324.9400
-309.5290
-237.2740
-466.8960
-640.0420
Net Income from Continuing & Discontinued Operation
-1,356.1770
-1,274.4710
-1,481.3700
-1,726.5710
-3,801.1180
Normalized Income
-1,336.7760
-1,272.6530
-1,296.0940
-1,348.7509
-2,775.7640
EBIT
-1,031.2370
-964.9420
-1,244.0960
-1,280.1520
-3,167.2260
EBITDA
-1,021.2260
-955.0860
-1,234.2050
-1,275.0610
-3,092.0610
Reconciled Depreciation
10.0110
9.8560
9.8910
5.0910
75.1650
Net Income from Continuing Operation Net Minority Interest
-1,356.1770
-1,274.4710
-1,481.3700
-1,726.5710
-3,801.1180
Total Unusual Items Excluding Goodwill
-19.4010
-1.8180
-185.2760
-382.3010
-1,027.0130
Total Unusual Items
-19.4010
-1.8180
-185.2760
-382.3010
-1,027.0130
Normalized EBITDA
-1,001.8250
-953.2680
-1,048.9290
-892.7600
-2,065.0480
Tax Rate for Calcs
--
--
--
0
0
Tax Effect of Unusual Items
--
--
--
-4.4809
-1.6590
12/31/2020 - 1/11/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

QPT.V Quest PharmaTech Inc.
0.0200
-33.33%
 
MMIRF MedMira Inc.
0.0800
0.00%
 
RP.V RepliCel Life Sciences Inc.
0.0150
0.00%
 
MIR.V MedMira Inc.
0.1200
0.00%
 
MLYS Mineralys Therapeutics, Inc.
9.56
+0.31%
 
HEM.V Hemostemix Inc.
0.1750
-7.89%
 
MDNA.TO Medicenna Therapeutics Corp.
1.1500
-4.17%
 
APGE Apogee Therapeutics, Inc.
34.55
+1.77%
 
CGON CG Oncology, Inc.
27.85
-1.31%
 
CRGX CARGO Therapeutics, Inc.
3.7700
+2.17%